CI stock verdict - Value
CI
The Cigna Group
VALUEHealthcare
$289.57
Strong Buy · trend up
$289.57
Heavy$418.11Buy$507.70Fair$597.29Exit$657.02
FUNDAMENTAL74
TECHNICAL77
TRUST SCORE
100High
confidence in this read — data completeness, earnings quality & coverage
Uptrend · EMA20 288.0 · EMA50 286.07 · EMA200 285.17 · RSI 51.7 · MACD below signal
PROS
- Trades 52% below the model's fair value ($597.29)
- Attractive trailing P/E of 12.3× (earnings yield 8.2%)
- Revenue grew 15.4%/yr on average over the last 3 years
- TTM EPS grew 30.8% year-over-year
- Healthy free-cash-flow yield of 10.0%
CONS
- Thin net margin of 2.1% (3-yr avg)
✳ Pros and cons are machine-generated from the latest fundamentals and technicals.
EARNINGS QUALITY · we check the accounting so you don't have to
✓Operating cash flow is 161% of net income — profit is backed by real cash
✓Low accruals — reported profit tracks the cash actually generated
✓Receivables growing in line with sales
SECTOR PEERS
Analysis as of 2026-07-27 · price live, fundamentals from latest filings
FAQ
Why is CI rated Value?
CI (The Cigna Group) is rated Value because the model combines fundamentals, price action, and earnings-quality checks. The current signal is Strong Buy · trend up. Trades 52% below the model's fair value ($597.29) and Attractive trailing P/E of 12.3× (earnings yield 8.2%)
Is CI overvalued right now?
CI is trading at $289.57 versus an estimated fair value of $597.29. That puts the stock in value territory on this framework. Thin net margin of 2.1% (3-yr avg)
What should I watch before acting on CI?
Watch the trust score of 100, the earnings-quality checks, and any red flags. Thin net margin of 2.1% (3-yr avg)